The Europe Veterinary Reference Laboratory Market was valued at $1309.6 Million in 2025 and projected to reach to $1747 Million by 2030, representing a compound annual growth rate of 5.9%. Europe's veterinary reference laboratory market is poised for sustained growth through 2030, supported by rising pet ownership, increasing awareness of animal health diagnostics, and investments in advanced laboratory technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe commands a mature veterinary reference laboratory market valued at USD 1,309.6 million in 2025, driven by established diagnostic infrastructure and stringent regulatory standards across member states.
The European market is projected to expand from USD 1,309.6 million (2025) to USD 1,747.0 million (2030) at a CAGR of 5.9%, outpacing global growth expectations in key segments.
Increasing pet ownership across Europe, particularly in Western European nations, is driving demand for advanced diagnostic services and specialized veterinary reference laboratory testing.
Europe's robust regulatory framework and compliance standards ensure high-quality diagnostic services, positioning the region as a benchmark for veterinary laboratory excellence globally.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | OTHER COMPANION ANIMALS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.3% from 2025 to 2030 |
| Largest Segment | VETERINARY CLINICS & HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 4.75 (2025) |
| Revenue Forecast (Billions) | ~USD 6.45 (2030) |
| Segments Covered | Service, Animal Type, Application, Type, End User |
5 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| OTHER END USERS | 18.07 | 18.56 | 19.21 | 19.91 | 20.66 | 21.46 | 22.31 | 23.23 | 3.9 |
| POINT-OF-CARE/IN-HOUSE LABS | 20.74 | 21.77 | 23.05 | 24.43 | 25.92 | 27.54 | 29.29 | 31.2 | 6.2 |
| RESEARCH INSTITUTES & UNIVERSITIES | 28.88 | 29.5 | 30.37 | 31.32 | 32.32 | 33.4 | 34.56 | 35.81 | 3.3 |
| VETERINARY CLINICS & HOSPITALS | 138.55 | 143.93 | 150.72 | 158.09 | 165.96 | 174.44 | 183.6 | 193.46 | 5.1 |
| TOTAL | 206.2 | 213.8 | 223.3 | 233.8 | 244.9 | 256.8 | 269.8 | 283.7 | 4.9 |
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| OTHER END USERS | 75.8 | 78.4 | 81.8 | 85.5 | 89.4 | 93.5 | 98.1 | 102.9 | 4.7 |
| POINT-OF-CARE/IN-HOUSE LABS | 120.8 | 128.1 | 136.9 | 146.5 | 156.9 | 168.4 | 180.9 | 194.6 | 7.3 |
| RESEARCH INSTITUTES & UNIVERSITIES | 168.3 | 173.5 | 180.4 | 187.8 | 195.7 | 204.2 | 213.4 | 223.3 | 4.4 |
| VETERINARY CLINICS & HOSPITALS | 821.7 | 861.5 | 910.6 | 964.1 | 1021.8 | 1084.4 | 1152.4 | 1226.2 | 6.1 |
| TOTAL | 1186.6 | 1241.6 | 1309.6 | 1383.9 | 1463.8 | 1550.5 | 1644.8 | 1747 | 5.9 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ABAXIS INC | United States | Private Company | Veterinary analyzers & consumables (VetScan, hematology, rapid tests),Human point-of-care chemistry (Piccolo analyzers and profiles),OEM/technology licensing and other (Orbos lyophilization, i-STAT related), |
| IDEXX LABORATORIES, INC. | United States | Public Company | Companion Animal Group (in-clinic analyzers, SNAP assays, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy (including human diagnostic products), |
| CVS (UK) LIMITED | United States | Public Company | Health Care Benefits,Health Services (PBM and related),Pharmacy & Consumer Wellness, |
| NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS | United States | U.S. Federal Government | Regulatory and confirmatory diagnostics,Reference methods, standards, and proficiency testing,Research, assay development, and validation services, |
| PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE | Italy | Private Company | Advanced clinical care (surgery, hospitalization, critical care),Diagnostics and imaging,Preventive and routine care, |
ABAXIS INC is a private company founded in 1989 in the United States with 656 employees.
IDEXX Laboratories, Inc. is a public company founded in 1983 in the United States with 11,000 employees.
CVS (UK) Limited is a public company founded in 1963 in the United States with 259,500 employees.
National Veterinary Services Laboratory USDA-APHIS is a U.S. federal government laboratory founded in 1961.
Private Veterinary Clinic San Marco SRL Unipersonale is a private company based in Italy.
| Country | 2025 size (native) |
|---|---|
| Germany | USD 139.13 Million |
| UK | USD 104.23 Million |
| France | USD 85.75 Million |
| Italy | USD 50.45 Million |
| Spain | USD 41.19 Million |
| Netherlands | USD 26.95 Million |
| Rest of Europe | USD 89.76 Million |
Europe's veterinary reference laboratory market is valued at USD 1,309.6 million in 2025 and is expected to reach USD 1,747.0 million by 2030.
Europe's veterinary reference laboratory market is projected to grow at a CAGR of 5.9% from 2025 to 2030.
Europe's market growth is driven by stringent animal health regulations, rising pet ownership, increased preventive care awareness, advanced diagnostic technology adoption, and laboratory consolidation across the region.
Europe's veterinary reference laboratories see strong demand for molecular diagnostics, digital pathology, companion animal testing, equine diagnostics, and exotic animal laboratory services.
By 2030, Europe's market is expected to see increased AI integration, expanded molecular diagnostic capabilities, greater digital pathology adoption, and continued consolidation among regional laboratory service providers.
This study extensively used both primary and secondary sources. The research involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
This research study utilized comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was employed to identify and collect information relevant to an in-depth, technical, market-oriented, and commercial study of the infusion pump market. It was also used to identify key players in the market and classify and segment the industry based on trends to the most detailed level. Additionally, significant developments related to market and technology perspectives were noted. A database of the primary industry leaders was also created using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary reference laboratory. Primary sources from the demand side include healthcare professionals from veterinary hospitals, veterinary clinics, and veterinary diagnostic centers.
A breakdown of the primary respondents is provided below:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the veterinary reference laboratory was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Veterinary reference laboratories refer to specialized diagnostic facilities that perform routine and advanced testing services for the detection, confirmation, and monitoring of animal diseases and disorders. These laboratories utilize a wide range of diagnostic methodologies, including clinical chemistry, hematology, immunodiagnostics, molecular diagnostics, urinalysis, microbiology, histopathology, toxicology, productivity testing, and pregnancy testing, to support evidence-based veterinary care. The market covers laboratory-based diagnostic services provided for companion and livestock animals by veterinary clinics and hospitals, research institutes, universities, point-of-care/in-house labs, government and public health agencies, and other end users. This report studies the market for such diagnostic services offered by reference laboratories while excluding laboratory software, imaging systems, and biopsy/necropsy services.
Full forecast, segment splits, and company analysis for all Veterinary Reference Laboratory Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report